المؤلفون: Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Primary and Long-term Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Eikholt AA; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., van de Hei SJ; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Muris JWM; Department of General Practice, Research Institute CAPHRI, Maastricht University, Maastricht, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases and Tuberculosis, University of Groningen University Medical Center Groningen, Groningen, The Netherlands., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

المصدر: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

المؤلفون: Achterbosch M; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands., van de Hei SJ; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, The Netherlands., Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, The Netherlands.; Observational and Pragmatic Research Institute, Singapore, Singapore.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van den Berge M; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases & Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, The Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, The Netherlands., van Dijk L; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands.; Nivel, Utrecht, The Netherlands.; Department of PharmacoTherapy, -Epidemiology & -Economics (PTEE), Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The Netherlands. j.f.m.van.boven@umcg.nl.

المصدر: NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2024 May 28; Vol. 34 (1), pp. 13. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Feasibility Studies* , Medication Adherence*/statistics & numerical data , Pulmonary Disease, Chronic Obstructive*/drug therapy , Asthma*/drug therapy , Nebulizers and Vaporizers*, Humans ; Male ; Female ; Middle Aged ; Administration, Inhalation ; Aged ; Adult

المؤلفون: van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore, Singapore; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Feb; Vol. 12 (2), pp. 396-398.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Anti-Asthmatic Agents*/therapeutic use, Humans ; Nebulizers and Vaporizers ; Administration, Inhalation

المؤلفون: Dierick BJH; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of General Practice & Elderly Care Medicine, Groningen, the Netherlands., Achterbosch M; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands., Eikholt AA; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., van de Hei SJ; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands., Hagedoorn P; University of Groningen, Groningen Research Institute of Pharmacy, Department of Pharmaceutical Technology and Biopharmacy, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Kerstjens HAM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Groningen, the Netherlands., Kocks JWH; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands; Observational and Pragmatic Research Institute, Singapore., van Boven JFM; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands. Electronic address: j.f.m.van.boven@umcg.nl.

المصدر: Respiratory medicine [Respir Med] 2023 Nov; Vol. 218, pp. 107376. Date of Electronic Publication: 2023 Aug 06.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy, Adult ; Humans ; Nebulizers and Vaporizers ; Administration, Inhalation ; Metered Dose Inhalers ; Medication Adherence ; Electronics

المؤلفون: Dierick BJH; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of General Practice & Elderly Care Medicine, Groningen, the Netherlands., Been-Buck S; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Klemmeier T; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Hagedoorn P; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., van de Hei SJ; University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, the Netherlands; General Practitioners Research Institute, Groningen, the Netherlands., Kerstjens HAM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Pulmonology and Tuberculosis, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Kocks JWH; General Practitioners Research Institute, Groningen, the Netherlands; Observational and Pragmatic Research Institute, Singapore; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., Zijp TR; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Wessels AMA; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands., Touw DJ; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands., van Boven JFM; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, the Netherlands. Electronic address: j.f.m.van.boven@rug.nl.

المصدر: Respiratory medicine [Respir Med] 2022 Sep; Vol. 201, pp. 106940. Date of Electronic Publication: 2022 Jul 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Bronchodilator Agents*/therapeutic use , Pulmonary Disease, Chronic Obstructive*/drug therapy, Administration, Inhalation ; Formoterol Fumarate/therapeutic use ; Humans ; Metered Dose Inhalers ; Nebulizers and Vaporizers

المؤلفون: van de Hei SJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands., Dierick BJH; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of General Practice and Elderly Care Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Aarts JEP; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore., van Boven JFM; Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia; Medication Adherence Expertise Center of the northern Netherlands, Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Nov; Vol. 9 (11), pp. 3979-3994. Date of Electronic Publication: 2021 Jun 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Pulmonary Disease, Chronic Obstructive*/drug therapy, Adult ; Humans ; Medication Adherence ; Nebulizers and Vaporizers

المؤلفون: van Boven JFM; Dept of Clinical Pharmacy and Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands j.f.m.van.boven@rug.nl.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands., Dierick BJH; Dept of Clinical Pharmacy and Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Usmani OS; Imperial College London and Royal Brompton Hospital, London, UK.

المصدر: The European respiratory journal [Eur Respir J] 2021 Sep 02; Vol. 58 (3). Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Asthmatic Agents*/therapeutic use , Asthma*/drug therapy , Asthma*/genetics, Humans ; Medication Adherence ; Pharmacogenetics

المؤلفون: Jansen EM; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van de Hei SJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Dierick BJH; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of General Practice & Elderly Care Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kerstjens HAM; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.; General Practitioners Research Institute (GPRI), Groningen, The Netherlands.; Observational and Pragmatic Research Institute (OPRI), Singapore., van Boven JFM; Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.

المصدر: Journal of thoracic disease [J Thorac Dis] 2021 Jun; Vol. 13 (6), pp. 3846-3864.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE

المؤلفون: Dierick BJH; University of Groningen, University Medical Center Groningen, Groningen Institute for Asthma and COPD (GRIAC), Department of General Practice & Elderly Care Medicine, Groningen, The Netherlands. b.j.h.dierick@umcg.nl., Flokstra-de Blok BMJ; General Practitioners Research Institute, Groningen, The Netherlands., van der Molen T; University of Groningen, University Medical Center Groningen, Groningen Institute for Asthma and COPD (GRIAC), Department of General Practice & Elderly Care Medicine, Groningen, The Netherlands., Toledo-Pons N; Department of Respiratory Medicine, Hospital Universitario Son Espases, and CIBERES, Madrid, Spain.; Instituto de Investigación Sanitaria de Baleares (IdISBa), Palma de Mallorca, Spain., Román-Rodríguez M; University of Groningen, University Medical Center Groningen, Groningen Institute for Asthma and COPD (GRIAC), Department of General Practice & Elderly Care Medicine, Groningen, The Netherlands.; Instituto de Investigación Sanitaria de Baleares (IdISBa), Palma de Mallorca, Spain.; Primary Care Health Service, Servei de Salut de les Illes Balears, Palma de Mallorca, Spain., Cosío BG; Department of Respiratory Medicine, Hospital Universitario Son Espases, and CIBERES, Madrid, Spain.; Instituto de Investigación Sanitaria de Baleares (IdISBa), Palma de Mallorca, Spain., Soriano JB; Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain., Kocks JWH; General Practitioners Research Institute, Groningen, The Netherlands., van Boven JFM; University of Groningen, University Medical Center Groningen, Groningen Institute for Asthma and COPD (GRIAC), Department of General Practice & Elderly Care Medicine, Groningen, The Netherlands.

المصدر: NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2021 Feb 16; Vol. 31 (1), pp. 9. Date of Electronic Publication: 2021 Feb 16.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/epidemiology , Pulmonary Disease, Chronic Obstructive*/epidemiology , Rhinitis, Allergic*, Cohort Studies ; Efficiency ; Humans

المؤلفون: Dierick BJH; Department of General Practice & Elderly Care Medicine, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC) , Groningen, The Netherlands., van der Molen T; Department of General Practice & Elderly Care Medicine, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC) , Groningen, The Netherlands., Flokstra-de Blok BMJ; Groningen Research Institute for Asthma and COPD (GRIAC) , Groningen, The Netherlands.; General Practitioners Research Institute , Groningen, The Netherlands., Muraro A; Food Allergy Centre, Department of Woman and Child Health, Padua University Hospital , Padua, Italy., Postma MJ; Department of Health Sciences, Unit of Global Health Economics, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands., Kocks JWH; Groningen Research Institute for Asthma and COPD (GRIAC) , Groningen, The Netherlands.; General Practitioners Research Institute , Groningen, The Netherlands., van Boven JFM; Groningen Research Institute for Asthma and COPD (GRIAC) , Groningen, The Netherlands.; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands.

المصدر: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2020 Oct; Vol. 20 (5), pp. 437-453. Date of Electronic Publication: 2020 Sep 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE

مواضيع طبية MeSH: Asthma/*epidemiology , Dermatitis, Atopic/*epidemiology , Food Hypersensitivity/*epidemiology , Rhinitis, Allergic/*epidemiology, Absenteeism ; Asthma/economics ; Cost of Illness ; Dermatitis, Atopic/economics ; Food Hypersensitivity/economics ; Humans ; Presenteeism/economics ; Quality of Life ; Quality-Adjusted Life Years ; Rhinitis, Allergic/economics ; Socioeconomic Factors